AMD plans an undisclosed equity investment in PsiQuantum as part of an expanded partnership to develop infrastructure for utility-scale quantum computers. The companies will combine AMD computing technology with PsiQuantum’s silicon photonics platform and develop applications integrating quantum computing with high-performance computing and AI.
AMD plans to make an equity investment in PsiQuantum as the companies expand their partnership to develop infrastructure for utility-scale quantum computers. They did not disclose the size of the investment.
AMD will provide CPUs, GPUs, adaptive computing technology and software, while PsiQuantum will contribute its silicon photonics platform. The companies will co-design infrastructure and develop applications combining quantum computing with high-performance computing and AI.
PsiQuantum’s drug research technology is already running on AMD hardware. The companies said their workflow and AMD’s GPU expertise produced initial breakthrough results simulating covalent inhibitors, a class of molecules relevant to oncology drug discovery.
